Vitamin Shoppe (NYSE: VSI) reported earnings on May 8. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Vitamin Shoppe beat expectations on revenues and beat expectations on earnings per share.

Compared with the prior-year quarter, revenue increased and GAAP earnings per share expanded significantly.

Margins improved across the board.

Revenue details
Vitamin Shoppe booked revenue of $248.1 million. The 12 analysts polled by S&P Capital IQ expected to see sales of $239.7 million on the same basis. GAAP reported sales were 14% higher than the prior-year quarter's $216.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.62. The 13 earnings estimates compiled by S&P Capital IQ predicted $0.57 per share. GAAP EPS of $0.61 for Q1 were 53% higher than the prior-year quarter's $0.40 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 35.6%, 90 basis points better than the prior-year quarter. Operating margin was 12.3%, 270 basis points better than the prior-year quarter. Net margin was 7.4%, 210 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $239.1 million. On the bottom line, the average EPS estimate is $0.49.

Next year's average estimate for revenue is $933.7 million. The average EPS estimate is $1.86.

Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 33 members out of 42 rating the stock outperform, and nine members rating it underperform. Among 20 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 12 give Vitamin Shoppe a green thumbs-up, and eight give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Vitamin Shoppe is outperform, with an average price target of $48.45.

Over the decades, small-cap stocks like Vitamin Shoppe have provided market-beating returns, provided they're value-priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Get instant access to this free report.